Interesting the article below from August 2019 shows Recce was listed as a company working with Dohertys back then. Investigating anti microbial resistance. I guess if they put them in the priority 1 category of treatments most likely to have effect in the upcoming trial that must be a positive as they have been looking at 327 for some time it would appear.
https://www.doherty.edu.au/news-events/news/arc-awards-5m-to-establish-research-hub-tackling-antimicrobial-resistance
Ann: RCE Selected by CSIRO/PDI for SARS-CoV-2 Antiviral Program, page-186
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.010(3.33%) |
Mkt cap ! $89.39M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 32.0¢ | 30.0¢ | $25.76K | 82.29K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 13550 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 18938 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |